Palisade Bio Reports First Quarter 2022 Financial Results and Provides Corporate Update
Phase 3 study of LB1148 in lead indication for postoperative return of bowel function on track to commence Q2 2022...
Year: 2022
Ceapro Inc. Present PGX Enabling Technology Case Study at the 13th International Symposium on Supercritical Fluids
PGX Technology continues to demonstrate ability to generate novel bioactive delivery systems for nutraceuticals, drug delivery and wound healingEDMONTON, Alberta,...
Sienna Announces May Dividend
MARKHAM, Ontario, May 13, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced...
ABVC BioPharma Engages the FreeMind Group to Support Grant Funding
FREMONT, CA, May 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical...
Ozop Energy Solutions, Inc. Attending Agent Summit 2022 Conference beginning May 15 in Las Vegas
Ozop Plus is Reinsurance Symposium Premier Sponsor Florida, NY, May 13, 2022 (GLOBE NEWSWIRE) -- Ozop Energy Solutions. Inc. (OZSC),...
Checkpoint Therapeutics Receives Pediatric Investigational Plan Waivers for Cosibelimab from the European Medicines Agency and U.K. Medicines & Healthcare Products Regulatory Agency
Waivers remove requirement to conduct pediatric clinical studies to support cosibelimab marketing authorization applications in EuropeWALTHAM, Mass., May 13, 2022...
POINT Biopharma Reports First Quarter 2022 Financial Results and Provides Business Update
POINT's manufacturing facility initiated supply for the Phase 3 SPLASH trial. Randomization of patients for the SPLASH trial expanded to...
Vallon Pharmaceuticals Announces $3.9 Million Registered Direct Offering
PHILADELPHIA, PA, May 13, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical...
Entourage Health Enters into Voting Support Agreement and Announces Proposed Amendments to its 8.5% Unsecured Convertible Debentures
Company looks to improve capital structure and create long-term value for all security holdersTORONTO, May 13, 2022 (GLOBE NEWSWIRE) --...
Best Delta 8 THC & CBD Products to Get a Head Start on Premium Hemp Quality
GLENDALE, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- The hemp products filled with different cannabinoids have become very popular as...
Outlook Therapeutics Reports Financial Results for Second Quarter Fiscal Year 2022 and Provides Corporate Update
ONS-5010 / LYTENAVA™ (bevacizumab-vikg) Biologics License Application (BLA) submitted to U.S. Food and Drug Administration (FDA); PDUFA date expected to...
Pyxis Oncology Reports Financial Results for the Quarter Ended March 31, 2022 and Provides Business Update
CAMBRIDGE, Mass., May 13, 2022 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a multi-asset multi-modality company focused on developing...
CytoDyn Announces the Addition of Leading Experts in Oncology, Infectious Diseases, and Neuroinflammation to its Scientific Board of Advisors; Dr. Jay Lalezari to Serve as Outside Scientific Advisor
VANCOUVER, Washington, May 13, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing...
NeuroPace to Present at the 2022 RBC Capital Markets Global Healthcare Conference
MOUNTAIN VIEW, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on...
Achieve Life Sciences Announces Participation at Best Ideas Virtual Investor Conference
SEATTLE and VANCOUVER, British Columbia, May 13, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical...
Longeveron Inc. Provides Corporate Update and Reports First Quarter 2022 Financial Results
Conference call scheduled for 8:30 a.m. ET todayMIAMI, May 13, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or...
Acutus Medical completes enrollment in IDE trial with its AcQBlate® FORCE Sensing Ablation System
AcQBlate FORCE System A complete ablation system which includes the smallest footprint of any RF Generator and is comprised of...
Progressive Care to Report First Quarter Financial Results on May 17, 2022
Progressive Care Inc. Has Scheduled an Investor Conference Call for 4:30 PM ET on Tuesday, May 17, 2022 MIAMI, FL,...
Tempest Reports First Quarter 2022 Financial Results and Provides Corporate Highlights
Announced oral presentation of TPST-1120 Phase 1 monotherapy and combination therapy data at ASCOPresented positive preclinical data for TPST-1495 at...
ProSomnus® Presents Data Validating Proprietary FDA-cleared Oral Appliance Therapy Devices at 2022 American Academy of Dental Sleep Medicine Annual Meeting
Data suggest ProSomnus’s patient-preferred devices can be suitable alternative to CPAPSAN FRANCISCO, May 13, 2022 (GLOBE NEWSWIRE) -- ProSomnus, the...
